Clinical Trial Update: Use of Nitroglycerine to Improve Signs of Poor Peripheral Perfusion in Patients With Traumatic Hemorrhagic Shock [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update examining nitroglycerin to improve signs of poor peripheral perfusion in patients with traumatic hemorrhagic shock; current stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemorrhagic Shock

Drugs mentioned

• NITROGLYCERIN (Nitroglycerin)

Snippet

Sponsor: Assiut University | Conditions: Hemorrhagic Shock | Phase 2 | Status: UNKNOWN